Issue navigation
Volume 17, Issue 5, May 2024
Editorial Comments
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae062, https://doi.org/10.1093/ckj/sfae062
Decreased life expectancy: a health outcome not corrected by kidney replacement therapy that emphasizes the need for primary prevention of CKD
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae053, https://doi.org/10.1093/ckj/sfae053
Sixty years of European Renal Association (ERA) Registry data on kidney disease: visualizing differences in clinical practice
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae120, https://doi.org/10.1093/ckj/sfae120
Can exercise improve outcomes for frail haemodialysis patients?
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae138, https://doi.org/10.1093/ckj/sfae138
Special Feature
Plain language summary of a study looking at the effect of empagliflozin treatment in patients with chronic kidney disease
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae057, https://doi.org/10.1093/ckj/sfae057
In Context
Factor XI antagonists: the discovery of the philosopher's stone?
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae106, https://doi.org/10.1093/ckj/sfae106
CKJ Reviews
Pre-gestational counselling for women living with CKD: starting from the bright side
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae084, https://doi.org/10.1093/ckj/sfae084
Acute kidney injury and point-of-care ultrasound in liver cirrhosis: redefining hepatorenal syndrome
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae112, https://doi.org/10.1093/ckj/sfae112
Genome editing and kidney health
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae119, https://doi.org/10.1093/ckj/sfae119
SGLT2 inhibition to target kidney aging
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae133, https://doi.org/10.1093/ckj/sfae133
Ten tips on how to assess bone health in patients with chronic kidney disease
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae093, https://doi.org/10.1093/ckj/sfae093
Original Articles
Maintained renin–angiotensin–aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae083, https://doi.org/10.1093/ckj/sfae083
Performances of acute kidney injury biomarkers vary according to sex
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae091, https://doi.org/10.1093/ckj/sfae091
Fractional excretion of total protein predicts renal prognosis in Japanese patients with primary membranous nephropathy
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae071, https://doi.org/10.1093/ckj/sfae071
Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort study
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae087, https://doi.org/10.1093/ckj/sfae087
Non-surgical interventions to control bleeding from arteriovenous fistulas and grafts inside and outside the hemodialysis unit: a scoping review
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae089, https://doi.org/10.1093/ckj/sfae089
A clinical score to predict recovery in end-stage kidney disease due to acute kidney injury
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae085, https://doi.org/10.1093/ckj/sfae085
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)—a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae109, https://doi.org/10.1093/ckj/sfae109
Prediction of incident chronic kidney disease in community-based electronic health records: a systematic review and meta-analysis
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae098, https://doi.org/10.1093/ckj/sfae098
Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae099, https://doi.org/10.1093/ckj/sfae099
Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae105, https://doi.org/10.1093/ckj/sfae105
Lumasiran treatment in pediatric patients with PH1: real-world data within a compassionate use program in Italy
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae090, https://doi.org/10.1093/ckj/sfae090
The efficacy and safety of tacrolimus in treating refractory IgA vasculitis nephritis: a single-center retrospective study on 16 cases
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae115, https://doi.org/10.1093/ckj/sfae115
Cognitive decline related to chronic kidney disease as an exclusion factor from kidney transplantation: results from an international survey
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae114, https://doi.org/10.1093/ckj/sfae114
Effects of Kt/Vurea on outcomes according to age in patients on maintenance hemodialysis
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae116, https://doi.org/10.1093/ckj/sfae116
Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of Health claims databases
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae117, https://doi.org/10.1093/ckj/sfae117
Effect of absolute blood volume measurement–guided fluid management on the incidence of intradialytic hypotension-associated events: a randomised controlled trial
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae128, https://doi.org/10.1093/ckj/sfae128
Deciphering three predominant biopsy-proven phenotypes of IgG4-associated kidney disease: a retrospective study
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae111, https://doi.org/10.1093/ckj/sfae111
[18F] AlF-NOTA-FAPI-04 PET/CT for non-invasive assessment of tubular injury in kidney diseases
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae064, https://doi.org/10.1093/ckj/sfae064
Tubular biomarkers in proteinuric kidney disease: histology correlation and kidney prognosis of tubular biomarkers
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae146, https://doi.org/10.1093/ckj/sfae146
Greater haemodialysis exposure (‘quotidian haemodialysis’) has different mortality associations by patient age group
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae103, https://doi.org/10.1093/ckj/sfae103
The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae126, https://doi.org/10.1093/ckj/sfae126
Exceptional Case
Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae127, https://doi.org/10.1093/ckj/sfae127
Letters to the Editor
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae107, https://doi.org/10.1093/ckj/sfae107
Outcomes of primary membranous nephropathy refractory to immunosuppressants
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae113, https://doi.org/10.1093/ckj/sfae113
Risk of first peritonitis episode in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: a population-based study
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae118, https://doi.org/10.1093/ckj/sfae118
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae122, https://doi.org/10.1093/ckj/sfae122
Correction
Correction to: Moving on obesity treatment in CKD: inertia is unjustified
Clinical Kidney Journal, Volume 17, Issue 5, May 2024, sfae149, https://doi.org/10.1093/ckj/sfae149
